Steven Gerbel
Chicago Capital Management, Llc
Assets Managed
$112.301M
Holdings
27
Last Quarter
2026 - Q2
Filed Date
1d ago
Growth Rate
-6.96%(2Q avg: -12.4%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Chicago Capital Management, Llc's 2026 - Q2 portfolio, based on their 13F SEC filing, out of a total of 27 positions.
Assets under management
The assets under management (AUM) of Chicago Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q2, they manage 112.301M in assets, with a quarterly growth rate of -6.96% and a 2-quarter average growth rate of -12.4%. The portfolio is managed by Steven Gerbel, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
NUVL Nuvalent Inc-a
| 9.85% | $11.053M 115,500 shares@ $95.7 avg price | New Position |
APGE Apogee Therapeutics Inc
| 8.74% | $9.807M 97,100 shares@ $101.01 avg price | New Position |
GTLS Chart Industries Inc
| 7.45% | $8.358M 53,000 shares@ $157.7 avg price | |
ur-1⤦ Bandwidth Inc
| 6.79% | $7.623M 8,153 shares@ $935.0 avg price | Increased 0.16% |
TMHC Taylor Morrison Home Corp
| 6.39% | $7.174M 133,000 shares@ $53.94 avg price | New Position |
ur-6⤦ Sabre Glbl Inc
| 6.35% | $7.123M 6,904 shares@ $1031.75 avg price | Increased 15.88% |
ur-3⤦ Rapid7 Inc
| 5.63% | $6.313M 6,520 shares@ $968.24 avg price | Increased 44.32% |
ur-5⤦ Mgp Ingredients Inc New
| 5.29% | $5.931M 6,068 shares@ $977.4 avg price | Increased 0.84% |
ur-6⤦ Veritone Inc
| 4.8% | $5.389M 5,500 shares@ $979.74 avg price | Increased 120% |
ur-1⤦ Amphastar Pharmaceuticals In
| 4.44% | $4.976M 5,440 shares@ $914.64 avg price | New Position |
1-10 of 27